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The role of extracellular ATP in almost all biologic 
systems has been shown since the idea was first proposed 
in the mid-1950s. The role of this nucleotide and other 
nucleotides became even more attractive when this molecule 
was identified as a component of the secretory granules and 
synaptic vesicles in neurosecretory systems [1]. Costorage 
with acetylcholine, monoamines, and even the acidic 
neurotransmitters glutamate and gamma-aminobutyric acid 
(GABA) makes ATP a relevant modulator of the activity of 
most synapses in the central nervous system (CNS) and in the 
autonomic nervous system [2].
In the eye, where the autonomic and central nervous 
systems control this organ, ATP, as a neurotransmitter or 
neuromodulator together with other nucleotides, plays an 
important function in the regulation of relevant neurophysi-
ological processes. Examples of the participation of nucleo-
tides in eye functions are involvement in tear secretion and 
ocular surface mucin release, a role in wound repair, the 
modulation of intraocular pressure (IOP), and the modulation 
of the retinal visual output [3]. In this sense, nucleotide and 
dinucleotide synthetic analogs may act as therapeutic agents 
for pathologies such as dry eye, glaucoma, and retinal detach-
ment [4, 5]. In the retina, ATP receptors, ionotropic P2X, 
and metabotropic P2Y receptors are present and probably 
modulate the synaptic transmission in this intricate ocular 
structure [6, 7].
Despite knowledge of the existence of receptors for ATP 
in the retina, little is known about the levels of ATP and its 
release in this area. This is a relevant point since ATP levels 
may change with aging and pathology, as was recently shown 
in the retinas of a murine model with Alzheimer disease [8].
One prevalent retinal disease that leads to blindness 
is glaucoma. This neuropathy affects retinal cells, mainly 
retinal ganglion cells [9-11]. Nucleotides such as ATP and 
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Purpose: To study retinal extracellular ATP levels and to assess the changes in the vesicular nucleotide transporter 
(VNUT) expression in a murine model of glaucoma during the development of the disease.
Methods: Retinas were obtained from glaucomatous DBA/2J mice at 3, 9, 15, and 22 months together with C57BL/6J 
mice used as age-matched controls. To study retinal nucleotide release, the retinas were dissected and prepared as flat-
tened whole mounts and stimulated in Ringer buffer with or without 59 mM KCl. To investigate VNUT expression, sec-
tions of the mouse retinas were evaluated with immunohistochemistry and western blot analysis using newly developed 
antibodies against VNUT. All images were examined and photographed under confocal microscopy. Electroretinogram 
(ERG) recordings were performed on the C57BL/6J and DBA/2J mice to analyze the changes in the electrophysiological 
response; a decrease in the scotopic threshold response was observed in the 15-month-old DBA/2J mice.
Results: In the 15-month-old control and glaucomatous mice, electrophysiological changes of 42% were observed. In 
addition, 50% increases in the intraocular pressure (IOP) were observed when the pathology was fully established. The 
responses in the retinal ATP net release as the pathology progressed varied from 0.32±0.04 pmol/retina (3 months) to 
1.10±0.06 pmol/retina (15 months; threefold increase). Concomitantly, VNUT expression was significantly increased dur-
ing glaucoma progression in the DBA/2J mice (58%) according to the immunohistochemical and western blot analysis.
Conclusions: These results may indicate a possible correlation between retinal dysfunction and increased levels of 
extracellular ATP and nucleotide transporter. These data support an excitotoxicity role for ATP via P2X7R in glaucoma. 
This modified cellular environment could contribute to explaining the functional and biochemical alterations observed 
during the development of the pathology.
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diadenosine tetraphosphate are present in higher concentra-
tions in the human aqueous humor in cases of acute and high-
pressure glaucoma, which suggests that these nucleotides 
participate in the etiology of the disease [12, 13]. Therefore, 
nucleotides elevated several fold may contribute to the ocular 
hypertension often associated with glaucoma probably by the 
activation of P2Y2 receptors present in the ciliary body as 
previously demonstrated [14]. This increase in nucleotide 
levels occurs in the anterior pole of the eye and may not 
reflect similar changes at the retinal level. Nevertheless, P2Y2 
receptor activation in the ciliary body increases IOP, and this 
elevation in pressure could be, at least in part, responsible 
for concomitant retinal damage. These alterations have been 
related to ATP receptors, P2X7 receptors in particular, present 
in retinal cells such as ganglion cells [15-19]. Interestingly, 
the expression of P2X7 receptors changes with the develop-
ment of glaucoma. Nevertheless, information regarding the 
levels of ATP during the development of the disorder, another 
critical point to fully establish the contribution of the P2X7 
receptor to the glaucomatous pathology, is lacking. ATP is 
normally stored in synaptic vesicles with the vesicular nucleo-
tide transporter (VNUT) [20-22]. This transporter is also 
useful to know what cells have ATP as a neurotransmitter, 
which is relevant in a complicated structure such as the retina.
In the present study, variation in the expression of the 
VNUT in the retina of normal and glaucomatous animals 
was investigated. In addition, and using the same models, 
the basal and stimulated release of ATP from whole mount 
retinas of normal and pathological animals was measured.
METHODS
Animal handling: Female C57BL/6J (n=16, for each stage) 
and DBA/2J (n=16, for each stage) mice obtained from the 
European distributor of Jackson Laboratory mice (Charles 
River Laboratories, Barcerlona, Spain) were used for this 
study. Mice were housed one to four mice per cage in 
temperature- and light-controlled rooms maintained on a 
12 h:12 h light-dark cycle (light from 8 AM to 8 PM) and 
with food and water ad libitum. The DBA/2J and C57BL/6J 
mice were divided into groups corresponding to different 
ages: 3, 6, 9, 15, and 22 months. All animal maintenance 
and experimental procedures were performed following 
the Spanish and European regulations of animal care in the 
laboratory and animal research (Guide for the Care and Use 
of Laboratory Animals) and the ARVO Statement for the Use 
of Animals in Ophthalmic and Vision Research. This study 
has been approved by the UCM-CEA with reference 45-2014 
and by the Madrid Enviromental Department with reference 
05/312824.9/14.
For IOP and electroretinogram (ERG) measurements, the 
mice were weighed and anesthetized with an intraperitoneal 
(i.p.) injection of a mixture of ketamine (95 mg/kg, Imalgene 
1000®, Merial, Barcelona, Spain) and xylazine (5 mg/kg, 
Rompún®, Bayer, S.A., Barcelona, Spain).
IOP measurements: Control (n=8, for each stage) and glau-
comatous mice (n=8, for each stage) were anesthetized and 
maintained on a warmed pad. The intraocular pressure was 
recorded by using a non-invasive rebound tonometer (Tono-
lab®; iCare Finland Oy, Helsinki, Finland) [23-26]. Both eyes 
of each animal were measured immediately after sedation 
[27] at the age of 3, 6, 9, 15, and 22 months, and IOP was 
always measured at the same time to avoid fluctuations due 
to the circadian rhythm [28, 29]. For each animal, IOP was 
presented as the average of six measurements taken for each 
eye.
Electroretinogram recordings: After the IOP measure-
ments, the same animals were dark-adapted overnight 
before the ERG recordings. All manipulation procedures 
were performed under dim red light (λ>600 nm) in absolute 
darkness. Mice were anaesthetized with an i.p. injection of a 
solution of ketamine (95 mg/kg) and xylazine (5 mg/kg) and 
maintained on a heating pad to preserve the normal body 
temperature at 37 °C. Pupil mydriasis was induced in each 
mouse by applying a drop of topical 1% tropicamide (Colir-
cusí Tropicamida 1% ®; Alcon-Cusí, S.A., El Masnou, Barce-
lona, Spain) in the right eye of each mouse. Scotopic threshold 
responses were recorded in response to light stimuli produced 
by a Ganzfeld stimulator using a Burian-Allen bipolar lens 
electrode (Briot Weko España, Barcelona, Spain) located on 
the cornea. Previously, the corneal surface was protected 
with a non-allergenic ionic conductive drop of methylcel-
lulose (Methocel 2%®; Novartis Laboratories CIBA Vision, 
Annonay, France). A copper electrode was placed in the 
mouth and served as the reference electrode, and the ground 
electrode was a needle placed subcutaneously at the base of 
the tail. Anesthetized mice were placed on the warming table 
in a Ganzfeld stimulator. The scotopic threshold responses 
(STRs) were recorded from the right eye in response to 
light stimuli (intensities ranged from 10−5 to 10−2 cd·s·m−2), 
provided by a Ganzfeld dome light source, which ensures the 
uniform illumination of the retina. For each light intensity, 
a series of ERG responses were averaged (approximately 20 
ERG responses for each trace), and the interval between light 
flashes was adjusted to ensure timing that allowed response 
recovery (10 s for the dimmest stimulus intensities). Electrical 
signals generated in the retina were amplified (1,000X) and 
band filtered between 0.3 and 1000 Hz with a Grass ampli-
fier (CP511 AC amplifier, Grass Instruments, Quincy, MA). 
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Electrical signals were digitized at 20 kHz using a Power Lab 
data acquisition board (AD Instruments, Chalgrove, UK) and 
displayed on a PC computer. Light stimuli were calibrated 
periodically with a photometer (Mavo Monitor USB, Gossen, 
Nürenberg, Germany). The recordings were analyzed with 
the normalization criteria established by the International 
Society for Clinical Electrophysiology of Vision (ISCEV) 
for measurement of the amplitude and implicit time of the 
different waves studied.
The STR was analyzed for each stimulus; positive STR 
(pSTR) was measured from the baseline to the peak of the 
positive deflection, approximately 110–120 ms from the flash 
onset, and the negative STR (nSRT) was measured from the 
baseline to the peak of the negative deflection after the pSTR, 
approximately 220 ms from the onset of the flash. ERG wave 
amplitudes were calculated for each animal group, and the 
percentage difference between the DBA/6J eyes and the 
control eyes was obtained for each stimulus and was further 
averaged (mean ± standard error of the mean, SEM).
Statistical analysis: The results were analyzed with GraphPad 
Instat® 3 for Windows® (GraphPad Software, San Diego, 
CA). Descriptive statistics were calculated, and the normality 
of the distribution of the data was examined. The Student t 
test was applied for the comparison between the mean ERG 
response of right eyes at −3.69 cd·sm−2 in the two animal 
models at different ages.
Retinal isolation and ATP samples analysis: The C57BL/6J 
and glaucomatous mice were euthanized at 3, 9, 15, and 23 
months (n=8 for each age) through decapitation on a sterile 
gauze pad. Both eyes were enucleated using sterile curved 
scissors to cut the optic nerve. Extra caution was needed to 
avoid damaging the retina. Eyecups were placed in Ringer’s 
solution and dissected under a stereomicroscope (SteREO 
Discovery.V8, Zeiss, Madrid, Spain). With 0.8 mm tip curved 
forceps and sterile fine-angled dissecting scissors, the cornea 
was severed. The forceps were then gently moved at a slight 
backward angle to pull up the cornea. Then the lens was 
removed with slight pressure on the eyecup. Gently, the retina 
was separated from the sclera, and the retina was cleaned of 
choroid pigment and vitreous.
Tissue samples were homogenized with dissecting scis-
sors and mechanic lysis in 10 volumes of ice-cold 5% trichlo-
roacetic acid (TCA) and transferred to 1.5 ml Eppendorf 
tubes. They were then centrifuged at 22,000 ×g for 10 min at 
4 °C. Supernatants were collected in a fresh tube and were 
neutralized with 2.5% hydroxide potassium (KOH) adjusted 
to an approximate pH value of 7.5. The samples were frozen 
until they were analyzed with high-pressure liquid chroma-
tography (HPLC).
After thawing, the samples were strongly vortexed for 2 
min. The ATP levels were analyzed in 20 μl of the TCA tissue 
extracts with HPLC using an isocratic pump (model 1515; 
Waters Madrid, Spain). The chromatographic conditions 
consisted of a C18 reverse-phase column, 250 mm long and 
4.6 mm in diameter (Hyperchrome, Scharlab, Madrid, Spain). 
It was equilibrated with a mobile phase containing 10 mM 
KH2PO4, 2 mM tetrabutylammonium bisulfate (TBA), and 
20% acetonitrile adjusted to pH 7.5 with 5 M KOH. The flow 
rate throughout the chromatographic runs was 2 ml/min. ATP 
was measured at the 260 nm wavelength.
The control retinas were maintained in Ringer solution, 
and the stimulated retinas were treated with 59 mM potassium 
Figure 1. Changes in the intraocular 
pressure and electroretinogram 
recordings in glaucomatous and 
control mice. A: Assessment 
of intraocular pressure (IOP) 
measurements in the glaucomatous 
(DBA/2J) and control (C57) mice 
as a function of age. Animals were 
measured at 3, 9, and 15 months 
of age. A significant increase was 
observed in DBA/2J mice at 12 
months when compared with the control mice (*p<0.05). B: Scotopic threshold responses from control C57BL/6J or DBA/2J glaucomatous 
mice as a function of age. Superposed averaged positive scotopic threshold response (pSTR) amplitudes were measured from the electro-
retinogram (ERG) flash response as a function of stimulus light intensity recorded from C57BL/6J (triangles) and DBA/2J (circles) mice at 
3 (white symbols), 9 (gray symbols), and 15 months (black symbols). Plot data correspond to mean values ± standard deviation (SD) (n=8). 
A significant reduction in the STR amplitudes in the DBA/2J mice between 3 and 15 months is observed for pSTR amplitudes (***p<0.001) 
and when compared with the control mice at 15 months ($p<0.001).
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chloride (KCl) in Ringer solution for 1 min. The supernatants 
(1,000 μl) were collected in 1.5 ml tubes and maintained in 
ice for 5 min. The tubes were heated in a 98 °C bath for 2 
min and then transferred to ice for 10 min, to precipitate the 
proteins. To pellet the proteins, the tubes were centrifuged at 
22,000 ×g for 10 min at 4 °C. The concentrations of released 
ATP were measured using reverse-phase HPLC and ultra-
violet (UV) detection as described above.
Immunohistochemical studies: The C57BL/6J and DBA/2J 
mice at 3, 9, 15, and 22 months of age (n=4 animals for each 
group) were anesthetized (see above) and perfused pericardi-
ally with 4% PBS (20 mM NaCl, 20 mM KCl, 10 mM NaPO4, 
5 mM KPO4, pH 7.4) paraformaldehyde in PBS 0.1 M at pH 
7.4. The eyes were enucleated, fixed in 4% paraformalde-
hyde (PFA) in PBS for 2 h at 4 °C, rinsed in 33% sucrose, 
and embedded in tissue freezing medium until frozen with 
liquid N2. Vertical sections of the retinas (10 μm thick) were 
Figure 2. Study of the ATP release 
in control (C57BL/6J) and glauco-
matous (DBA/2J) mice. A: Basal 
and KCl stimulated ATP release 
from whole mount retinas obtained 
from the C57BL/6J mice. The left 
panel represents the mean of the 
ATP amounts at the given mice 
ages either under basal (solid 
symbol) or stimulated conditions 
(open symbol). The middle and 
right panels are representative 
high-pressure liquid chromatog-
raphy (HPLC) elution profiles of 
basal (middle panel) and stimulated 
conditions (right panel). B: Basal 
and KCl stimulated ATP release 
from whole mount retinas obtained 
from glaucomatous DBA/2J mice. 
The left panel shows the mean 
of the ATP amounts at the given 
mice ages either under basal (solid 
symbol) or stimulated conditions 
(open symbol). The middle and 
right panels are representative 
HPLC elution profiles of the basal 
(middle panel) and stimulated 
conditions (right panel). C: Net 
ATP release in the glaucomatous 
DBA/2J mice (open circles) and 
the control C57BL/6J mice (open 
squares) followed from 3 to 22 
months. D: Total ATP content in 
the retinas of the control and glau-
comatous mice at the different ages 
under study (n=8). *p<0.05 between 
9 and 15 months of age in the DBA/2J animals. #p<0.05 C57BL/6J mice versus DBA/2J mice at 15 months and ##p<0.01 C57BL/6J versus 
DBA/2J mice at 22 months.
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collected from the central retinal regions. Frozen sections 
were rinsed in PBS 1X and permeated with PBS-0.25% 
Tx-100 solution for 30 min. To avoid non-specific staining, 
sections were blocked in 10% normal donkey serum (NDS; 
Jackson ImmunoResearch, West Grove, PA) for 1 h at room 
temperature. Then, the primary antibody rabbit anti-solute 
carrier family 17 member 9 (anti-VNUT, ABN110; Milli-
pore, Billerica, MA) was incubated at 1:300 dilution at 4 °C 
overnight. The primary antibody used in this study has been 
used in the mouse retina [30]. Then sections were washed in 
PBS-0.1% Tx-100 and incubated with donkey anti-immuno-
globulin (IgG) rabbit antibody conjugated with fluorescein 
isothiocyanate (FITC; green; 1:200; Jackson ImmunoRe-
search), diluted in PBS-0.1% Tx-100 for 1 h in darkness at 
room temperature. The nuclei were stained with propidium 
iodide (red, Sigma) diluted 1:500 in PBS for 10 min. The 
sections were finally mounted in Vectashield (Vector Labo-
ratories, Palex Medical, Barcelona, Spain) and coverslipped. 
For the analysis, the images were acquired using a laser-
scanning microscope (Zeiss LSM 5, Jena, Germany).
Western blot: Thirty-two mice were used for the western 
blot analysis. Twelve C57BL/6J mice (n=4 for each stage) 
were used as the control, and 12 DBA/2J mice (n=4 for each 
stage) were used to evaluate the possible expression changes 
in the VNUT transporter at 3, 9, 15, and 22 months of age. 
Retinas were removed and homogenized in ice with radioim-
munoprecipitation assay (RIPA) buffer (1:5 v/v) containing 
50 mM HEPES, pH 8, 150 mM NaCl, 1% NP-40 (w/v), 0.5% 
sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 
and inhibitor proteases (1 mM phenyl methanesulfonyl fluo-
ride (PMSF), 10 µg/ml leupeptin, 5 µg/ml pepstatin, 10 µg/
ml aprotinin, 1 mM sodium fluoride, and 2 mM sodium 
orthovanadate). The lysates were centrifuged at 15,000 ×g 
for 15 min at 4 °C. The supernatant was stored at −80 °C 
until use.
The protein concentration was determined with Bradford 
assay. Retinal samples (40 µg protein) were diluted in Laem-
mli’s sample buffer, loaded on 10% SDS–polyacrylamide gel 
electrophoresis (PAGE) gels, and transferred to a nitrocellu-
lose membrane. Blots were blocked with 5% non-fat dry milk 
for 1 h at room temperature, and then they were incubated 
overnight at 4 °C in TBS 1X 0.1% Tween-20 containing 5% 
non-fat milk (blocking buffer) and VNUT primary antibody 
(Millipore). Mouse monoclonal glyceraldehyde-3-phosphate 
dehydrogenase (anti-GAPDH 1:500; Santa Cruz, Dallas, 
CA) served as a loading control. Membranes were incubated 
with goat anti-IgG rabbit antibody or goat anti-IgG mouse 
antibody conjugated with horseradish peroxidase secondary 
antibody (Jackson ImmunoResearch) for 1 h at room tempera-
ture. Then the proteins were revealed with chemilumines-
cence using enhanced chemiluminescence (ECL) detection 
(Amersham Phamacia Biotech, Barcelona, Spain). Films were 
scanned with the Gel Logic 200 Imaging System (Kodak, 
Rochester, NY). The densitometric analysis was performed 
by using Kodak Molecular Imaging software (Kodak). The 
densitometry values of each sample were normalized to the 
respective densitometric GAPDH values.
Statistical analysis: Data were plotted as the mean ± stan-
dard error of the mean (SEM). Where indicated, analyses of 
significance were performed using the Student t test followed 
by Welch’s test or one-way analysis of variance (ANOVA) 
followed by the Bonferroni correction to determine statis-
tical significance (GraphPad InStat software, Prism, La Jolla, 
CA). For correlations, Pearson bivariate regression was used. 
p<0.05 was considered statistically significant.
Figure 3. Correlation between electroretinogram recordings, ATP 
and vesicular nucleotide transporter expression. Relationship 
between ERG amplitude and ATP levels (A) and ERG amplitude 
and VNUT expression (B). Correlation was performed in glauco-
matous animals comparing 3 versus 15 months of age.
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Figure 4. Immunohistochemistry 
for VNUT in C57BL/6J and 
DBA/2J retinas. Vertical sections 
at 3, 9, 15, and 22 months of retinas 
from glaucomatous mice (B, C, 
E, F) and control mice at 3 and 15 
months (A, D). Vesicular nucleo-
tide transporter (VNUT)-stained 
retinas (green) showed a significant 
increase at 15 months in the DBA/2J 
mice (E) compared to that observed 
in the DBA/2J and C57BL/6J mice 
at 3 months (A, B) and 23 months 
(F). G–H: High magnification of 
the photoreceptor layer, showing 
an increase in VNUT labeling in 
the DBA/2J mice at 15 months 
(G) and VNUT staining found in 
ganglion cells (arrows; H). Nuclei 
were stained with propidium iodide 
(red). All images were collected 
from the central area of the retina. 
ONL, outer nuclear layer; OPL, 
outer plexiform layer; INL, inner 
nuclear layer; IPL, inner plexiform 
layer; GCL, ganglion cell layer. 
Scale bar: 20 μm.
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RESULTS
Changes in intraocular pressure in control and glaucomatous 
mice: To evaluate whether IOP changes occurred during the 
progression of the pathology, measurements were performed 
in the right and left eyes of female DBA/2J mice between 
3 and 15 months. IOP experiments were not performed at 
22 months of age since the pathology also produces corneal 
thickness increase and calcification, which makes it difficult 
to accurately measure IOP at that age [31].
IOP was measured for the C57BL/6J mice aged 3 and 15 
months as the control. The mean IOP before the development 
of glaucomatous damage was 13±3 mmHg (3 months).
At 9 months of age, an increase of 50% in the IOP was 
observed in the DBA/2J mice compared with the same 
strain at 3 months, which was the maximum at 12 months 
(27±5 mmHg). The evolution of IOP is shown in Figure 1A at 
3, 6, 9, 12, and 15 months. Between 3 and 9 months, the IOP 
remained constant in the eyes with glaucoma. No differences 
were found in IOP in the control mice. Measurements from a 
total of eight mice per age group were included.
Visual function is reduced in glaucomatous mice: To study 
the affectation of glaucomatous changes in the ganglion cells 
of the DBA/2J mice, the STR of the ERG was evaluated 
during the progression of the pathology. Glaucomatous mice 
and age-matched control mice were measured at 3, 9, and 15 
months of age.
Figure 1B shows the STRs. ERG recordings were elic-
ited with light stimuli of intensity ranging −5.00 to −2.94 log 
cd·s·m−2. The pSTR amplitudes for the DBA/2J mice were 
studied as a function of age. The average amplitude of the 
pSTR waves was measured from the ERG flash response as 
a function of stimulus light intensity. Significantly decreases 
(39.2% and 75%) were observed between 3, 9, and 15 months 
of age in the glaucomatous mice.
A significant decrease of 42% in the ERG wave ampli-
tude was also observed in the DBA/2J mice compared to 
the C57BL/6J animals tested at 15 months of age. The STR 
traces of the control mice showed no significant differences 
when the different time intervals were compared. A slight 
non-significant age-dependent decrease in the amplitudes of 
the pSTR obtained from 3- and 15-month-old C57BL6/J mice 
was observed.
Presence of extracellular ATP in stimulated and non-stim-
ulated retinas: The experiment with the nucleotide ATP in 
the retinas of the normal and glaucomatous animals showed 
interesting results. The evolution of the ATP concentra-
tions in the wild-type mouse (C57BL6/J) showed a gradual 
decrease in the basal extracellular and stimulated ATP release 
(Figure 2A).
In contrast, when the same experiments were performed 
in the glaucomatous DBA/2J mice, there were no significant 
changes in the basal ATP levels until the 22nd month (at 15th 
months, the ATP value was 1.02±0.50 pmol/mg per retina) 
while there was a huge increase to 8.13±0.33 pmol/mg per 
retina at 22 months of age (Figure 2B).
The release of ATP from the retinas of the glaucomatous 
mice when they were challenged with 59 mM KCL demon-
strated that changes were measurable at 15 months (ATP: 
2.62±0.45 pmol/mg per retina) compared to 9 months (ATP: 
1.13±0.31 pmol/mg per retina), and increased enormously at 
22 months; the ATP concentration was 8.99±0.57 pmol/mg 
per retina (Figure 2B).
Interestingly, when the net release was studied in the 
DBA/2J mouse, a clear increase in the ATP-stimulated 
release at 15 months was observed (ATP: 1.10±0.06 pmol/mg 
per retina) while at 22 months, the ATP concentration was not 
as high (0.86±0.08 pmol/mg per retina; Figure 2C).
Figure 5. VNUT expression in the 
glaucomatous and control retinas 
at different ages (3, 9, 15, and 22 
months). A: Detection of vesicular 
nucleotide transporter (VNUT) 
(68 kDa) levels in the C57BL/6J 
mice at 3, 9, and 15 months and in 
the DBA/2J mice at 3, 9, 15, and 22 
months by western blotting. The 
glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH; 37 kDa) levels 
are shown as a loading control. B: Western blot analysis of the VNUT at 3, 9, 15, and 22 months of age. Values are the mean ± standard 
deviation (SD) of six independent animal experiments (***p<0.001).
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When the total amount of ATP was measured in both 
mice strains at the indicated ages, an increase was observed 
in the nucleotide in the control and glaucomatous animals. 
The changes were more marked in the case of the DBA/2J 
mice, from 106.96±15.15 pmol/mg per retina at 9 months to 
186.33±45.23 pmol/mg per retina (Figure 2D, n=8).
The ATP concentration and VNUT expression showed a 
strong correlation in the DBA/2J model; the Pearson’s corre-
lation coefficient was −0.961 (p<0.0001; Figure 3).
VNUT expression of DBA/2J mice increases with the develop-
ment of the pathology: Immunohistochemistry was performed 
to evaluate the expression pattern of the VNUT in the retinas 
of the glaucomatous and control mice. Figure 4A-H shows 
a fixed mouse retina labeled for the vesicular nucleotide 
transporter. VNUT immunoreactivity was observed in the 
outer segments and in photoreceptors in the glaucomatous 
retinas (Figure 4G), in the outer plexiform layer (OPL), inner 
plexiform layer (IPL), inner nuclear layer (INL), and ganglion 
cell layer (GCL).
There was little change in the VNUT labeling in 
C57BL/6J retinas at 3 months compared to those from DBA/2J 
animals at the same age (Figure 4A,B). The expression levels 
of the ATP vesicular transporter remained the same in the 
control mice at 9 and 22 months (data not shown). The label 
and distribution of VNUT remained constant in the OPL, 
the IPL, and the inner cells (the INL, the GCL) at 9 months 
(Figure 4C). However, in the 15-month-old DBA/2J retinas 
(Figure 4E), there was a clear increase in VNUT expression 
in the plexiform layers (OPL and IPL), the INL, and the GCL. 
In contrast, at 23 months of age, there was a marked reduction 
in the vesicular nucleotide transporter labeling in the DBA/2J 
retinas; the expression was similar to that before the develop-
ment of the pathology (3 months; Figure 4A-H).
Figure 5A–B shows quantification of VNUT expres-
sion with western blot analysis. A significant increase in 
the VNUT level was found in the DBA/2J mice between 3 
and 15 months of age, compared to the age-matched control 
C57BL/6J mice (47.21%; p<0.001). However, the VNUT 
levels in the 22-month-old mice decreased compared to 
15 months, 38.72% (p<0.001). ERG amplitude and VNUT 
expression showed a strong correlation in the DBA/2J model; 
the Pearson’s correlation coefficient was −0.86 (p<0.0001; 
Figure 3). The VNUT expression of the control mice showed 
no significant differences among the different age groups 
studied.
DISCUSSION
Changes in ATP concentrations and in VNUT in the glauco-
matous animals and the control animals were investigated. 
Animals with glaucoma developed the pathology starting 
from the 9th month, the moment at which the IOP started to 
increase and a concomitant deterioration in the retinal elec-
trophysiological pattern occurred [3]. In a parallel way, a clear 
and gradual increase was observed in the extracellular levels 
of ATP that was highest in the latest stages of the pathology, 
particularly at 22 months of age in the DBA/2J mouse. Inter-
estingly, when the total ATP was measured in the animal 
retinas, a gradual increase with age was observed, which 
was more evident in the glaucomatous animals. It could be 
that due to this cytoplasmic increase in the nucleotide in 
the retinal cells, the elevation in VNUT is a mechanism for 
reducing the ATP concentrations within the cells. This could 
be why at 22 months compared to 15 (in the DBA) although 
the total amount of ATP is almost identical, the release at 22 
months is lower. More experiments are necessary to fully 
demonstrate this point.
Increased levels of retinal ATP have been recently 
described in a murine model of Alzheimer disease (AD). An 
increase in the levels of ATP in basal and stimulated condi-
tions was observed in the AD mice (AβPP). Interestingly, the 
increase in the extracellular concentrations of ATP peaked 
when this disorder was fully established but decreased during 
advanced stages of the disease [7]. In contrast, in the present 
work, in the glaucomatous model, there was an increase in 
ATP levels that lasted until 22 months of age. Despite this 
apparent difference between the AD model and glaucoma 
model, when the net release was studied, a similar behavior 
was observed. In this sense, the net release of ATP in the 
glaucomatous mice increased between the 9th and the 12th 
month decreased at 22 months. In the AD mice model, the 
net release of ATP peaked at 14 months, and the nucleotide 
was reduced at 18 months. In both cases, as the disease 
progressed, the peak in extracellular ATP diminished when 
the pathology was advanced. The reduction in ATP release 
when glaucoma is advanced may reflect retinal cell death. 
Ganglion cell death is a typical feature of this pathology as we 
have previously described in the DBA/2J model [32].
In parallel, we measured the expression of the vesicular 
nucleotide transporter in normal and glaucomatous animals. 
VNUT distribution in the retina suggests an important role 
for the delivery of ATP as a neurotransmitter. ATP released 
in the inner retina could contribute to activating the P2 puri-
nergic receptors [6]. Among all receptors and in relation to 
the possible cell death detected at 22 months of age, the acti-
vation of P2X7 receptors may occur. If so, their involvement 
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may activate signaling pathways, which promotes apoptotic 
mechanisms. Selective apoptosis mediated by P2X7 recep-
tors has been demonstrated in the photoreceptors when 
intravitreal injections of ATP are performed [33, 34]. This 
P2X7 receptor–induced apoptosis has also been detected in 
retinal ganglion cells [35, 36]. Environmental factors such as 
hypoxia or an acute increase in hydrostatic pressure induced 
retinal ganglion cell death due to the increase in extracellular 
ATP, which activates P2X7 receptors [37-39].
Western blot analysis of VNUT demonstrated a signifi-
cant increase in the expression of this protein at 15 months in 
the glaucomatous mice in contrast to the decrease observed 
as the animals were 22 months old. Nonetheless, and as 
described in [19], the vesicular transporter for ATP is present 
in the cells, in the outer and inner retina. This indicates that 
ATP is stored and released by the classical exocytotic way. 
The reduction in the VNUT when the glaucomatous animals 
were 22 months old and the reduction in the net release of 
ATP (although the total extracellular ATP concentrations 
increased) suggests that most of this ATP is due to cell death 
and the consequent release to the extracellular milieu.
One important aspect is the sequence of events during 
the advance of the pathology. The first events that occur in 
the anterior pole, the increase in IOP, peaked when there 
were no significant changes in retinal activity, ATP levels, 
or VNUT expression. Significant changes in ERG, ATP, and 
VNUT levels did not occur until the mice were 15 months 
old. Interestingly, when the mice were 22 months old, VNUT 
expression was clearly reduced. Nevertheless, the extracel-
lular presence of ATP peaked, which suggests massive cell 
death with the concomitant presence of the nucleotide in the 
extracellular medium.
Finding in which retinal neurons the VNUT is present 
is of great interest. ATP is costored with transmitters such 
as acetylcholine [40], noradrenaline [41], other monoamines 
[42], and glutamate [43] in the central nervous system. If there 
is an equivalent cotransmission in the retina, it would be 
feasible to find ATP as a transmitter in starburst-cholinergic 
amacrine cells (A18 wide-field and amacrine displaced cells, 
and others), dopaminergic amacrine and interplexiform cells, 
and glutamatergic bipolar and ganglion cells. In the present 
case, we can only suggest the presence of the VNUT in the 
inner nuclear layer and in ganglion cells. The precise descrip-
tion of which cells contain the VNUT deserves attention, but 
this is not the aim of the present work, which focused on the 
presence of the ATP transporter in the plexiform layers.
In summary, we have demonstrated that the levels of ATP 
and its vesicular transporter change during the development 
of the pathology. This increase may in part be responsible 
for the electrophysiological changes in the retinas of the 
glaucomatous mice. From a pharmacological point of view, 
considering the connection glaucoma-ATP increase-retinal 
injury, it might be of interest to abolish or block excess ATP 
and to see whether this blockade can protect the retina from 
glaucomatous damage.
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